Zhang W, Huang X
Biomark Res. 2025; 13(1):43.
PMID: 40075527
PMC: 11905658.
DOI: 10.1186/s40364-025-00750-w.
Ma L, Luan Y, Lu L
Cancer Med. 2025; 14(5):e70622.
PMID: 40062730
PMC: 11891933.
DOI: 10.1002/cam4.70622.
Goldman O, DeFoe A, Qi Y, Jiao Y, Weng S, Houri-Zeevi L
bioRxiv. 2025; .
PMID: 40060408
PMC: 11888250.
DOI: 10.1101/2025.02.25.639765.
Tan B, Xu K, Lyu Y, Liang Y, Liang R, Lei K
Commun Biol. 2025; 8(1):394.
PMID: 40057671
PMC: 11890618.
DOI: 10.1038/s42003-025-07819-0.
Guan F, Wang R, Yi Z, Luo P, Liu W, Xie Y
Signal Transduct Target Ther. 2025; 10(1):93.
PMID: 40055311
PMC: 11889221.
DOI: 10.1038/s41392-025-02124-y.
Cellular interactions within the immune microenvironment underpins resistance to cell cycle inhibition in breast cancers.
Griffiths J, Cosgrove P, Medina E, Nath A, Chen J, Adler F
Nat Commun. 2025; 16(1):2132.
PMID: 40032842
PMC: 11876604.
DOI: 10.1038/s41467-025-56279-x.
Blood TCTP as a potential biomarker associated with immunosuppressive features and poor clinical outcomes in metastatic gastric cancer.
Kim H, Jung S, Bang Y, Kim J, Kim H, Lee H
J Immunother Cancer. 2025; 13(3).
PMID: 40032602
PMC: 11877152.
DOI: 10.1136/jitc-2024-010455.
Single-cell and spatial genomic landscape of non-small cell lung cancer brain metastases.
Tagore S, Caprio L, Amin A, Bestak K, Luthria K, DSouza E
Nat Med. 2025; .
PMID: 40016452
DOI: 10.1038/s41591-025-03530-z.
Divide and Conquer-Targeted Therapy for Triple-Negative Breast Cancer.
Nedeljkovic M, Vuletic A, Mirjacic Martinovic K
Int J Mol Sci. 2025; 26(4).
PMID: 40003864
PMC: 11855393.
DOI: 10.3390/ijms26041396.
Towards the Prediction of Responses to Cancer Immunotherapy: A Multi-Omics Review.
Tao W, Sun Q, Xu B, Wang R
Life (Basel). 2025; 15(2).
PMID: 40003691
PMC: 11856636.
DOI: 10.3390/life15020283.
Comprehensive Analysis of TCR and BCR Repertoires: Insights into Methodologies, Challenges, and Applications.
Seo K, Choi J
Genomics Inform. 2025; 23(1):6.
PMID: 39994831
PMC: 11853700.
DOI: 10.1186/s44342-024-00034-z.
Comprehensive analysis of lipid metabolic signatures identified CEBPD promotes breast cancer cell proliferation.
Zhao Y, He H, Huang L, Yu L
Sci Rep. 2025; 15(1):6570.
PMID: 39994306
PMC: 11850814.
DOI: 10.1038/s41598-025-90869-5.
Safety and Antitumor Activity of a Novel aCD25 Treg Depleter RG6292 as a Single Agent and in Combination with Atezolizumab in Patients with Solid Tumors.
Gambardella V, Ong M, Rodriguez-Ruiz M, Machiels J, Sanmamed M, Galvao V
Cancer Res Commun. 2025; 5(3):422-432.
PMID: 39983024
PMC: 11891644.
DOI: 10.1158/2767-9764.CRC-24-0638.
Cancer stem cells and tumor-associated macrophages as mates in tumor progression: mechanisms of crosstalk and advanced bioinformatic tools to dissect their phenotypes and interaction.
Verona F, Di Bella S, Schirano R, Manfredi C, Angeloro F, Bozzari G
Front Immunol. 2025; 16:1529847.
PMID: 39981232
PMC: 11839637.
DOI: 10.3389/fimmu.2025.1529847.
Glycogen metabolism genes as a molecular signature for subtyping, prognostic prediction, and immunotherapy selection in clear cell renal cell carcinoma.
Ni F, Tan X, Zhang J, Guo T, Yuan Z, Wang X
Clin Exp Med. 2025; 25(1):61.
PMID: 39961952
PMC: 11832626.
DOI: 10.1007/s10238-025-01592-4.
Single-cell RNA sequencing identifies molecular biomarkers predicting late progression to CDK4/6 inhibition in patients with HR+/HER2- metastatic breast cancer.
Luo L, Yang P, Mastoraki S, Rao X, Wang Y, Kettner N
Mol Cancer. 2025; 24(1):48.
PMID: 39955556
PMC: 11829392.
DOI: 10.1186/s12943-025-02226-9.
Role of CD4 T cells in cancer immunity: a single-cell sequencing exploration of tumor microenvironment.
An Q, Duan L, Wang Y, Wang F, Liu X, Liu C
J Transl Med. 2025; 23(1):179.
PMID: 39953548
PMC: 11829416.
DOI: 10.1186/s12967-025-06167-1.
Metabolic Singularities in Microsatellite-Stable Colorectal Cancer: Identifying Key Players in Immunosuppression to Improve the Immunotherapy Response.
Gorria T, Sierra-Boada M, Rojas M, Figueras C, Marin S, Madurga S
Cancers (Basel). 2025; 17(3).
PMID: 39941865
PMC: 11815897.
DOI: 10.3390/cancers17030498.
Taming Variability in T-Cell Mechanosensing.
Schultheiss P, Pulkundwar A, Li W, Kam L
Cells. 2025; 14(3).
PMID: 39936994
PMC: 11817355.
DOI: 10.3390/cells14030203.
Mapping T cell dynamics to molecular profiles through behavior-guided transcriptomics.
Wezenaar A, Pandey U, Keramati F, Hernandez-Roca M, Brazda P, Barrera Roman M
Nat Protoc. 2025; .
PMID: 39930061
DOI: 10.1038/s41596-024-01126-4.